期刊文献+

Clusterin与Bax在大肠腺癌中的表达及意义

Expression and Significance of Clusterin and Bax in Colorectal Adenocarcinoma
下载PDF
导出
摘要 目的:探讨Clusterin(聚集蛋白,CLU)、Bax在大肠腺癌进展过程中的表达情况、作用及其之间的相关性。方法:利用免疫组织化学法检测CLU、Bax蛋白的表达情况,分析其表达结果与临床病理间的关系。结果:CLU在大肠腺癌中的表达明显高于大肠正常黏膜(P<0.01),表达情况与有无淋巴结转移、浸润程度、Dukes分期及肿瘤组织分化程度呈正相关(P<0.01),与性别及年龄无关。CLU与Bax的表达呈负相关(r=-0.58,P<0.01)。结论:CLU高表达与Bax的低表达在大肠腺癌的发生过程中起到重要作用。 Objective: To investigate the Clusterin(CLU) and Bax in colorectal cancer progression of the expression, function and the relationship between. Methods: The expression of CLU was detected by immunohistochemistry, Bax protein, to analyze the relationship between the expression and the clinical pathological results. Results:The expression of CLU in colorectal carcinoma was significantly higher than that of normal colorectal mucosa(P〈0.01), expression and lymph node metastasis, invasion, Dukes stage and differentiation of tumor tissue was positively correlated(P〈0.01), but has nothing to do with gender and age. Expression of CLU was negatively correlated with Bax(r=-0.58, P〈0.01). Conclusion: The high expression of CLU and low expression of Bax plays an Important role in the process of colorectal adenocarcinoma.
出处 《中国医药导刊》 2015年第7期655-656,共2页 Chinese Journal of Medicinal Guide
基金 承德市科技支撑计划项目(20132038) 项目名称:Clusterin Bcl-2 Bax及P53在大肠腺癌组织中的表达及相关性研究
关键词 大肠腺癌 CLUSTERIN BAX 免疫组织化学 Colorectal adencocarcinoma Clusterin Bax Immunohistochemist
  • 相关文献

参考文献11

  • 1Kukhta VK, Marozkina NK, Sokolchik IG, et al. Molecular mechanisms of apoptosis [J]. Ukr Biokhim Zh, 2003;75(6):5-9.
  • 2Cheng CY, Chcrng SH,Wu WJ,et al. Reply to: Clustcrin inhihition to enhance tumor chemosensitivity in systemic tumors[J], cancer Chemother Pharmacol,2013;71 (4): 1103-1104.
  • 3Burguilles MA,Hajji N,Englund E,et al. Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus evidence in Parkinson' s disease oafieum[J] .Neurobiol Dis.2010;9 (17): 1- 12.
  • 4Zielinski RR, Eigl B J, Chi KN.Targeting the apoptosis pathway in prostate cancer[J]. Cancer J, 2013,19 (1):79-89.
  • 5Zoubeidi A,Chi K,Glcavc M. Tart;etint; the eytcprctectivc chaperone,clusterin,for treatment of advanced caneer[J]. Clinical Cancer Research,2010,16:1088-1093.
  • 6Miyake H, Yamanaka K, Muramaki M, et al. Enhanced expression of secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatecto-my for prostate cancer[J].Oncol Rep,2011,14 (5): 1371-1375.
  • 7Kang YK, Hong SW, Lee H, et al. Overexpression of CLU in human hepatocellular carcinoma[J]. Hun Pathol, 2004,35(11):1340-1346.
  • 8Panico F, Casali C, Rossi G, et al. Prognostic role of elusterin in reseeted adenocarcinomas of the lung [J].Lung Cancer,2012;79(3) :294-299.
  • 9张印春,张丽娜,齐立强,顾林,付丽,范宇.乳腺浸润性导管癌组织中Bag-1、Bcl-2、Bax的表达变化及意义[J].山东医药,2012,52(2):60-61. 被引量:6
  • 10Niu ZH,Wang Y, Chun B, et al. Secretory(lustcfin ( sCLU ) ovcrex-pressicm is associated with resistance to preoperative ncoadjuvantchemotherapy in primary breast exneer[J]. Eur Rev Med PharmacoISci,2013;17(10): 1337-1344.

二级参考文献13

  • 1刘雪梅,黄剑飞.Bcl-2,Bax在乳腺癌中表达的临床意义[J].河南肿瘤学杂志,2005,18(1):14-16. 被引量:11
  • 2Yunis JJ, Oken MM, Kaplan ME, et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin "s lymphoma [J]. N Engl J Med,1982,307(20) :1231-1236.
  • 3Ohvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death[JJ. Ce11,1993,74(4) :609-619.
  • 4Takayama S, Sato T, Krajewski S, et al. Cloning and functional a- nalysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity [ J ]. Cell, 1995,80 (7) :279-284.
  • 5Tang SC, Shehata N, Chemenko G, et al. Expression of BAG-1 in invasive breast carcinomas [ J ]. J Clin Oncol, 1999,17 ( 11 ) : 1710- 1719.
  • 6Froesch BA, Takayama S, Reed JC. BAG-1L protein enhances an- drogen receptor function [ J ]. J Biol Chem, 1998,273 ( 19 ) : 11660- 11666.
  • 7Zapata JM, Krajewska M, Krajewski S, et al. Expression of multi- ple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors [ J ]. Breast Cancer Res Treat, 1998,47 ( 12 ) : 129- 140.
  • 8Turner BC, Krajewski S, Krajewska M, et al. BAG-1 : a novel bi- omarker predicting long-term survival in early-stage breast cancer [J]. J Clin Oncol,2001,19(4) :992-1000.
  • 9Wang HG, Takayama S, Rapp UR, et al. Bcl-2 interacting pro- tein, BAG-1, binds to and activates the kinase Raf-1 [ J]. Proc Natl Acad Sci USA, 1996,93 (14) :7063-7068.
  • 10Linjawi A, Kontogiannea M, Halwani F, et al. Prognostic signifi- cance of p53, bcl-2, and Bax expression in early breast cancer [ J]. J Am Coll Surg,2004,198 ( 1 ) :83-90.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部